import type { Metadata } from "next";
import Navigation from "@/components/Navigation";
import Footer from "@/components/Footer";

export const metadata: Metadata = {
  title: "Fasting Insulin, Hyperinsulinemia, and Early Metabolic Risk",
  description:
    "A clinical deep dive into fasting insulin, why normal glucose markers can miss early metabolic dysfunction, and how to act before cardiometabolic disease becomes obvious.",
  alternates: {
    canonical: "https://veridian-clinic.vercel.app/blog/fast-insulin",
  },
  openGraph: {
    title: "Fasting Insulin: The Missing Link in Early Metabolic Disease",
    description:
      "Why fasting glucose and HbA1c can look normal while hyperinsulinemia silently drives visceral fat, fatigue, and vascular risk.",
    url: "https://veridian-clinic.vercel.app/blog/fast-insulin",
    type: "article",
  },
};

const articleSchema = {
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Article",
      headline: "Fasting Insulin: The Missing Link in Early Metabolic Disease",
      description:
        "A clinical explainer on fasting insulin, hyperinsulinemia, Kraft patterns, and proactive metabolic medicine.",
      author: {
        "@type": "Person",
        name: "Dr Oluwatosin Taiwo",
      },
      publisher: {
        "@type": "Organization",
        name: "Veridian Clinic",
        url: "https://veridian-clinic.vercel.app",
      },
      mainEntityOfPage: "https://veridian-clinic.vercel.app/blog/fast-insulin",
      articleSection: "Metabolic Health",
      keywords: [
        "fasting insulin",
        "hyperinsulinemia",
        "metabolic dysfunction",
        "ApoB",
        "insulin resistance",
        "Kraft curve",
      ],
    },
    {
      "@type": "MedicalWebPage",
      name: "Fasting Insulin Clinical Guide",
      url: "https://veridian-clinic.vercel.app/blog/fast-insulin",
      about: [
        { "@type": "MedicalCondition", name: "Insulin Resistance" },
        { "@type": "MedicalCondition", name: "Hyperinsulinemia" },
      ],
      audience: {
        "@type": "MedicalAudience",
        audienceType: "Patient",
      },
      publisher: {
        "@type": "MedicalBusiness",
        name: "Veridian Clinic",
      },
    },
  ],
};

const faqs = [
  {
    question: "What is a healthy fasting insulin level?",
    answer:
      "Context matters, but in preventive metabolic medicine we generally want fasting insulin comfortably low rather than merely 'within range'. Many high-functioning adults with levels above 5 to 7 mIU/L are already compensating for declining insulin sensitivity, even if fasting glucose still looks normal.",
  },
  {
    question: "Can I have normal HbA1c and still be metabolically unwell?",
    answer:
      "Yes. HbA1c and fasting glucose are late markers. The pancreas can keep glucose artificially normal for years by secreting more insulin. That compensation delays diagnosis and is exactly why fasting insulin can be so clinically useful earlier in the timeline.",
  },
  {
    question: "Does high fasting insulin mean I have diabetes?",
    answer:
      "Not necessarily. It often signals pre-pre-diabetic physiology, meaning the body is under metabolic strain before diabetes thresholds are crossed. That is precisely the stage where intervention is most valuable, because the system is still highly reversible.",
  },
  {
    question: "Why is ApoB relevant if we are talking about insulin?",
    answer:
      "Because hyperinsulinemia and insulin resistance often travel with a more atherogenic lipid pattern. ApoB reflects the number of circulating atherogenic particles. If insulin is elevated and ApoB is also high, the concern is no longer just weight or energy, but long-term vascular risk.",
  },
  {
    question: "What actually lowers fasting insulin?",
    answer:
      "Usually not a single hack. The strongest levers are improved body composition, resistance training, better sleep, reduced grazing, strategic meal timing, adequate protein, and overall energy balance. In clinic, the goal is to combine those levers in a way a patient can sustain.",
  },
];

function Section({ eyebrow, title, children }: { eyebrow: string; title: string; children: React.ReactNode }) {
  return (
    <section className="fi-section">
      <p className="fi-eyebrow">{eyebrow}</p>
      <h2 className="fi-h2">{title}</h2>
      <div className="fi-copy">{children}</div>
    </section>
  );
}

export default function FastInsulinPage() {
  return (
    <div className="fi-page">
      <script
        type="application/ld+json"
        dangerouslySetInnerHTML={{ __html: JSON.stringify(articleSchema) }}
      />
      <Navigation />

      <main>
        <section className="fi-hero">
          <div className="fi-wrap fi-hero-grid">
            <div>
              <p className="fi-kicker">Clinical Metabolic Medicine</p>
              <h1 className="fi-h1">Fasting Insulin is often the earliest warning sign that metabolism is drifting off course.</h1>
              <p className="fi-subtitle">
                Long before HbA1c rises or fasting glucose breaches a lab threshold, insulin can be climbing in the background,
                silently buying "normality" at a physiological cost. If you care about performance, body composition, and long-term
                vascular health, this is one of the most informative markers to understand.
              </p>
              <div className="fi-cta-row">
                <a href="/book?tier=baseline" className="fi-btn fi-btn-primary">Book Baseline Audit</a>
                <a href="/assessments" className="fi-btn fi-btn-secondary">View Assessments</a>
              </div>
            </div>
            <aside className="fi-panel">
              <p className="fi-panel-label">Why it matters</p>
              <ul className="fi-bullets">
                <li>Often abnormal years before glucose markers.</li>
                <li>Tracks early insulin resistance and compensatory hyperinsulinemia.</li>
                <li>Helps explain visceral fat gain, post-meal crashes, and stubborn weight loss.</li>
                <li>Becomes more powerful when paired with ApoB, waist metrics, and body composition.</li>
              </ul>
            </aside>
          </div>
        </section>

        <div className="fi-wrap fi-content-shell">
          <Section eyebrow="The Problem" title="Why standard glucose tests can miss early metabolic dysfunction">
            <p>
              In conventional medicine, metabolic disease is often detected relatively late. A patient develops impaired fasting glucose,
              HbA1c drifts upward, and only then does the conversation become urgent. The problem is that glucose is usually the last
              thing to move. The body fights hard to keep blood sugar in a narrow range, and it does so by increasing insulin output.
            </p>
            <p>
              That means a person can appear "normal" on standard screening while already living in a state of escalating metabolic stress.
              The pancreas is working harder, skeletal muscle is becoming less responsive, visceral fat is accumulating, and energy regulation
              becomes less stable. On paper, nothing looks dramatic. Under the surface, compensation is underway.
            </p>
            <p>
              This is why fasting insulin matters. It gives you a glimpse of how much hormonal effort is required to maintain normal glucose.
              In practical terms, it can reveal early dysfunction while there is still a large window to reverse course.
            </p>
          </Section>

          <Section eyebrow="The Science" title="Hyperinsulinemia, Kraft curves, and the biological age penalty">
            <p>
              Hyperinsulinemia simply means insulin levels are inappropriately high relative to the metabolic task at hand. It is often the
              earliest detectable stage of insulin resistance. Dr Joseph Kraft demonstrated decades ago that many people with normal glucose
              tolerance tests showed abnormal insulin response curves, patterns that revealed metabolic disease hiding in plain sight.
            </p>
            <div className="fi-image-placeholder">[Kraft Curve Diagram]</div>
            <p>
              That insight still matters. Two people can share the same glucose reading, but one may require far more insulin to hold that line.
              Clinically, those are not equivalent states. Higher insulin exposure alters substrate partitioning, suppresses lipolysis, encourages
              fat storage, and reflects a system becoming less metabolically flexible.
            </p>
            <p>
              I think of this as a biological age penalty. You may be chronologically 38, 44, or 51, but if your insulin dynamics resemble someone
              much further along the cardiometabolic disease curve, your tissues are paying interest on that mismatch. The cost shows up as reduced
              resilience, poorer body composition, less stable energy, and greater downstream vascular risk.
            </p>
          </Section>

          <Section eyebrow="The Missing Link" title="Why elevated insulin can drive visceral fat, fatigue, and vascular risk">
            <p>
              Elevated insulin is not just a lab curiosity. It changes how the body behaves. High insulin makes it harder to access stored fat,
              which is one reason some people feel they are doing "everything right" yet cannot meaningfully change waist circumference. It also
              contributes to the feast-and-crash rhythm many high-performers describe, especially when meals are frequent, sleep is poor, or training
              is inconsistent.
            </p>
            <p>
              It also intersects with vascular biology. Insulin resistance commonly clusters with elevated triglycerides, lower HDL, rising blood
              pressure, inflammatory drift, and more atherogenic lipoprotein patterns. This is where ApoB becomes crucial. ApoB tells us how many
              atherogenic particles are circulating. If fasting insulin is high and ApoB is also elevated, the story is bigger than weight management.
              We are now looking at the mechanics of accelerated cardiovascular risk.
            </p>
            <div className="fi-image-placeholder">[Insulin, Visceral Fat, and ApoB Risk Pathway]</div>
            <p>
              For patients who want a Medicine 3.0 approach, this is the point. Do not wait for obvious disease. Identify the pattern early, quantify
              it properly, and intervene while physiology is still adaptable.
            </p>
          </Section>

          <Section eyebrow="Practical Protocols" title="What actually moves fasting insulin in the right direction">
            <p>
              The answer is rarely a supplement or a gimmick. It is usually a structured reduction in metabolic friction.
            </p>
            <p>
              <strong>Chronological nutrition</strong> means reducing the constant insulin demand created by grazing, late eating, and disordered meal timing.
              Many patients benefit from clearly defined meal windows, higher-protein first meals, fewer refined carbohydrate exposures, and a longer overnight fast.
              The aim is not dietary ideology. The aim is giving insulin time to return to baseline.
            </p>
            <p>
              <strong>Strength training</strong> is one of the most powerful tools in the system. Skeletal muscle is the primary glucose sink. Build more of it,
              use it regularly, and insulin sensitivity tends to improve. This is why a serious resistance programme often outperforms endless cardio when the goal is
              durable metabolic change.
            </p>
            <p>
              <strong>Clinical measurement</strong> matters because guesswork is expensive. In practice we want fasting insulin interpreted alongside fasting glucose,
              HbA1c, triglycerides, HDL, liver markers, waist metrics, blood pressure, body composition, and ideally ApoB. The value is in the pattern, not in one number alone.
            </p>
            <div className="fi-cta-card">
              <div>
                <p className="fi-cta-label">Clinical next step</p>
                <h3>Build a baseline before symptoms become disease.</h3>
                <p>
                  If your energy, waistline, or recovery feel off despite "normal" labs, a metabolic baseline can show whether insulin is the hidden driver.
                </p>
              </div>
              <a href="/book?tier=baseline" className="fi-btn fi-btn-primary">Book Baseline Audit</a>
            </div>
          </Section>

          <Section eyebrow="FAQ" title="Common patient questions about fasting insulin">
            <div className="fi-faqs">
              {faqs.map((faq) => (
                <div key={faq.question} className="fi-faq">
                  <h3>{faq.question}</h3>
                  <p>{faq.answer}</p>
                </div>
              ))}
            </div>
          </Section>
        </div>
      </main>

      <Footer />

      <style>{`
        :global(body) {
          background: #f6f2ea;
          color: #102418;
        }

        .fi-page {
          min-height: 100vh;
          background:
            radial-gradient(circle at top right, rgba(200,168,75,0.16), transparent 28%),
            linear-gradient(180deg, #f7f3eb 0%, #f3efe6 100%);
        }

        .fi-wrap {
          width: min(1120px, calc(100% - 32px));
          margin: 0 auto;
        }

        .fi-hero {
          padding: 120px 0 72px;
          border-bottom: 1px solid rgba(16, 36, 24, 0.08);
        }

        .fi-hero-grid {
          display: grid;
          grid-template-columns: 1.5fr 0.85fr;
          gap: 32px;
          align-items: start;
        }

        .fi-kicker,
        .fi-eyebrow,
        .fi-panel-label,
        .fi-cta-label {
          font-size: 0.78rem;
          letter-spacing: 0.16em;
          text-transform: uppercase;
          color: #8d6a1d;
          font-weight: 700;
          margin: 0 0 14px;
        }

        .fi-h1,
        .fi-h2,
        .fi-faq h3,
        .fi-cta-card h3 {
          font-family: "Cormorant Garamond", Georgia, serif;
        }

        .fi-h1 {
          font-size: clamp(2.8rem, 5vw, 5rem);
          line-height: 0.95;
          margin: 0 0 22px;
          color: #0d2818;
          max-width: 12ch;
        }

        .fi-subtitle,
        .fi-copy p,
        .fi-faq p,
        .fi-bullets li,
        .fi-cta-card p {
          font-size: 1.12rem;
          line-height: 1.85;
          color: rgba(16, 36, 24, 0.84);
        }

        .fi-cta-row {
          display: flex;
          gap: 14px;
          flex-wrap: wrap;
          margin-top: 28px;
        }

        .fi-btn {
          display: inline-flex;
          align-items: center;
          justify-content: center;
          padding: 14px 22px;
          border-radius: 999px;
          text-decoration: none;
          font-weight: 700;
          transition: transform 0.15s ease, opacity 0.15s ease, background 0.15s ease;
        }

        .fi-btn:hover {
          transform: translateY(-1px);
          opacity: 0.96;
        }

        .fi-btn-primary {
          background: #113422;
          color: #f6f2ea;
          box-shadow: 0 10px 30px rgba(17, 52, 34, 0.14);
        }

        .fi-btn-secondary {
          background: transparent;
          color: #113422;
          border: 1px solid rgba(17, 52, 34, 0.18);
        }

        .fi-panel,
        .fi-cta-card,
        .fi-image-placeholder,
        .fi-faq {
          background: rgba(255, 255, 255, 0.72);
          border: 1px solid rgba(17, 52, 34, 0.1);
          box-shadow: 0 12px 40px rgba(16, 36, 24, 0.05);
          backdrop-filter: blur(8px);
        }

        .fi-panel {
          border-radius: 28px;
          padding: 28px;
          position: sticky;
          top: 110px;
        }

        .fi-bullets {
          margin: 0;
          padding-left: 20px;
          display: grid;
          gap: 14px;
        }

        .fi-content-shell {
          padding: 56px 0 92px;
        }

        .fi-section {
          max-width: 860px;
          margin-bottom: 64px;
        }

        .fi-h2 {
          font-size: clamp(2.2rem, 4vw, 3.5rem);
          line-height: 1;
          margin: 0 0 18px;
          color: #0d2818;
        }

        .fi-copy p {
          margin: 0 0 20px;
        }

        .fi-image-placeholder {
          border-radius: 24px;
          padding: 32px;
          margin: 28px 0;
          text-align: center;
          color: #8d6a1d;
          font-weight: 700;
          letter-spacing: 0.06em;
        }

        .fi-cta-card {
          margin-top: 30px;
          padding: 28px;
          border-radius: 28px;
          display: flex;
          align-items: center;
          justify-content: space-between;
          gap: 20px;
        }

        .fi-cta-card h3 {
          margin: 0 0 10px;
          font-size: 2rem;
          line-height: 1;
          color: #0d2818;
        }

        .fi-faqs {
          display: grid;
          gap: 18px;
        }

        .fi-faq {
          border-radius: 24px;
          padding: 24px;
        }

        .fi-faq h3 {
          margin: 0 0 10px;
          font-size: 1.9rem;
          line-height: 1.05;
          color: #0d2818;
        }

        .fi-faq p:last-child,
        .fi-copy p:last-child {
          margin-bottom: 0;
        }

        @media (max-width: 900px) {
          .fi-hero-grid {
            grid-template-columns: 1fr;
          }

          .fi-panel {
            position: static;
          }

          .fi-cta-card {
            flex-direction: column;
            align-items: flex-start;
          }
        }
      `}</style>
    </div>
  );
}
